Supplementary Figure 2 from Genome-wide CRISPR Screen Reveals RAB10 as a Synthetic Lethal Gene in Colorectal and Pancreatic Cancers Carrying SMAD4 Loss

Erasimus, Hélène; Kolnik, Vanessa; Lacroix, Frédéric; Sidhu, Sukhvinder; D'Agostino, Stéphane; Lemaitre, Olivier; Rohaut, Alexandre; Sanchez, Isabelle; Thill, Gilbert; Didier, Michel; Debussche, Laurent; Marcireau, Christophe

doi:10.1158/2767-9764.22761828.v1

Supplementary Figure 2 from Genome-wide CRISPR Screen Reveals RAB10 as a Synthetic Lethal Gene in Colorectal and Pancreatic Cancers Carrying SMAD4 Loss

journal contribution

posted on 2023-05-04, 14:20 authored by Hélène Erasimus, Vanessa Kolnik, Frédéric Lacroix, Sukhvinder Sidhu, Stéphane D'Agostino, Olivier Lemaitre, Alexandre Rohaut, Isabelle Sanchez, Gilbert Thill, Michel Didier, Laurent Debussche, Christophe Marcireau

<p>S2. Quality check of the CRISPR screen samples.</p>

Funding

Sanofi (Sanofi US)

History

Related Materials

1.
DOI - Is supplement to Genome-wide CRISPR Screen Reveals RAB10 as a Synthetic Lethal Gene in Colorectal and Pancreatic Cancers Carrying SMAD4 Loss

ARTICLE ABSTRACT

This study identified and validated RAB10 as new synthetic lethal gene with SMAD4. This was achieved by conducting a whole-genome CRISPR screens in different colorectal and pancreatic cell lines. A future RAB10 inhibitors could correspond to a new therapeutic solution for patients with cancer with SMAD4 deletion.